SPIMACO CEO contract ends; Ahmed Aljedai to stay in charge

28/08/2025 Argaam
SPIMACOappointed Ahmed Aljedai asVice Chairman and Managing Director as of last April

SPIMACO appointed Ahmed Aljedai as Vice Chairman and Managing Director as of last April


Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said the extension period for Jerome Cabanas’ contract as CEO will conclude on Aug. 31, 2025.

 

In a statement on Tadawul, the company said Managing Director Ahmed Aljedai will continue leading the executive team, as part of efforts to boost efficiency and ensure continuity of the company’s strategies and long-term goals.

 

For more news on listed companies

 

Aljedai holds an MBA and a PhD in pharmacy, with over 30 years of experience in healthcare and pharmaceuticals. He previously chaired SPIMACO’s board during the April 2025-ended term.

 

Last April, SPIMACO appointed Aljedai as Vice Chairman and Managing Director, according to Argaam’s data.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.